SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274644-13-000055
Filing Date
2013-11-14
Accepted
2013-11-14 16:53:43
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocera3q10q.htm 10-Q 907075
2 EXHIBIT 31.1 ocrxexhibit3113q2013.htm EX-31.1 16631
3 EXHIBIT 31.2 ocrxexhibit3123q2013.htm EX-31.2 17232
4 EXHIBIT 32.1 ocrxexhibit3213q2013.htm EX-32.1 7577
5 EXHIBIT 32.2 ocrxexhibit3223q2013.htm EX-32.2 7519
  Complete submission text file 0001274644-13-000055.txt   5801854

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tzym-20130930.xml EX-101.INS 770629
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tzym-20130930.xsd EX-101.SCH 39716
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tzym-20130930_cal.xml EX-101.CAL 62192
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tzym-20130930_def.xml EX-101.DEF 214230
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tzym-20130930_lab.xml EX-101.LAB 530951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tzym-20130930_pre.xml EX-101.PRE 329084
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 131221033
SIC: 2834 Pharmaceutical Preparations